Although a range
of pharmacologically active compounds has been
obtained from the mycelium and fruiting bodies of Ganoderma
lucidum, the biological properties of the alkaloids
present in this functional food remain unknown. Herein, we report
total syntheses of lucidimines B and C, key members of the first family
of alkaloids isolated from G. lucidum, and the evaluation of these synthetically derived materials as
antioxidants and antiproliferative agents. Lucidimine B proved to
be a better antioxidant than congener C. Similarly, lucidimine B exhibited
antiproliferative properties toward MCF-7 cells (an EC50 value of 0.27 ± 0.02 μmol/mL), whereas lucidimine C was
inactive. The former alkaloid arrested the MCF-7 cell cycle in the
S phase by inducing DNA fragmentation, hence reducing the mitochondrial
membrane potential. This work thus demonstrates, for the first time,
that the alkaloidal constituents derived from G. lucidum are biologically active and may, therefore, contribute to the beneficial
health claims made for this nutraceutical.